[ad_1] Some therapies used to treat cancer may increase the risk of later developing secondary hematologic malignancies. A population-based study in Japan has revealed a […]
[ad_1] Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer cases, yet remain an understudied group, […]
[ad_1] Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study springermedicine.com [ad_2]